Axway Track & Trace manages serialized and non-serialized product events to allow internal and external...
The life sciences industry involves many participants from various organisations, requiring each to have visibility into controlled substances as they move through the supply chain process, while still maintaining security and compliance regulations.
Axway, a market leader in governing the flow of data, has today announced its Controlled Substance Ordering System (CSOS) is now available as an Axway Cloud service, powered by Amazon Web Services (AWS).
This new availability gives Axway CSOS users easy access and interaction with trading partners to manage regulated pharmaceuticals within the supply chain, while reducing operational expenses, increasing security and ensuring real-time compliance with US Drug Enforcement Administration (DEA) regulations.
The electronic pharmaceutical supply chain contains various organizations of all sizes including controlled substance suppliers, manufacturers, purchasers, pharmacies, practitioners, retailers, federal agencies, service providers, and distributors.
Organizations within the pharmaceutical supply chain that are looking to replace costly paper-based Form 222 with the electronic Form e222 are shifting to central, cloud-based signing and audit tracking, and away from internally managed solutions, which are difficult to implement and support.
By providing all of the functionality organizations need to manage an electronic B2B relationship, including certificate management, trading partner and community management, secure communications and tracking, Axway Cloud CSOS service is enabling companies to comply with DEA audit requests efficiently, while drastically decreasing implementation times and costs. In addition, Axway solutions for governing the flow of data are deployed in a highly secure private cloud, eliminating the risks of accidental data leakage.
With Axway Cloud CSOS Service, now available as part of the broader Axway 5 Suite Cloud services portfolio, companies have greater visibility into controlled substance transactions to monitor and track the location of the product as it moves through the pharmaceutical supply chain. Axway enterprise class Cloud CSOS Service is engineered to meet Service Organizations Control 1 (SOC 1)/SSAE16/ISAE 3402, CFR21 Part 11 and Drummond-certified to meet FIPS140 requirements.
"Launched more than 15 years ago, the Axway CSOS solution has long been field-proven, and over that time it has evolved to meet the ever-changing demands of our customers and DEA regulations," said Dean Hidalgo, executive vice-president, marketing, Axway. "Early adopters have embraced Cloud CSOS Service because it delivers a hassle free solution that meets DEA regulations, as well as integrates simply and seamlessly with buyers such as pharmacies, practitioners and distributors’ procurements systems. CSOS availability as an Axway Cloud Service demonstrates our ongoing commitment to the safe distribution of prescription drugs of all classifications."